HealthEquity (FRA:2HE) COGS-to-Revenue

: 0.37 (As of Jan. 2024)

View and export this data going back to 2014. Start your Free Trial

HealthEquity's Cost of Goods Sold for the three months ended in Jan. 2024 was €89.0 Mil. Its Revenue for the three months ended in Jan. 2024 was €240.9 Mil.

HealthEquity's COGS to Revenue for the three months ended in Jan. 2024 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. HealthEquity's Gross Margin % for the three months ended in Jan. 2024 was 63.06%.

HealthEquity COGS-to-Revenue Historical Data

The historical data trend for HealthEquity's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 0.39 [6] => 0.43 [7] => 0.44 [8] => 0.43 [9] => 0.38 )

HealthEquity Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

COGS-to-Revenue

0.39

0.43

0.44

0.43

0.38

HealthEquity Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
COGS-to-Revenue																0.42	0.40	0.38	0.36	0.37

HealthEquity COGS-to-Revenue Calculation

HealthEquity's COGS to Revenue for the fiscal year that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	346.04	/	917.621
	=	0.38

HealthEquity's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	88.967	/	240.871
	=	0.37

HealthEquity (FRA:2HE) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

HealthEquity's Gross Margin % for the three months ended in Jan. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	88.967 / 240.871
	=	63.06 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

HealthEquity COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of HealthEquity's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

HealthEquity (FRA:2HE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (FRA:2HE) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

HQY:USA

Address

15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020

Website

https://www.healthequity.com

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

HealthEquity (FRA:2HE) Headlines

No Headlines